RedHill BiopharmaJazz Pharmaceuticals Completes Zanidatamab Biologics License Application For Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
RedHill BiopharmaJazz Pharmaceuticals Completes Zanidatamab Biologics License Application For Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
RedHill BiopharmaJazz Pharmaceuticals 完成了先前治療的 HER2 陽性轉移性膽道癌的 Zanidatamab 生物製劑許可證申請
RedHill BiopharmaJazz Pharmaceuticals Completes Zanidatamab Biologics License Application For Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
RedHill BiopharmaJazz Pharmaceuticals 完成了先前治療的 HER2 陽性轉移性膽道癌的 Zanidatamab 生物製劑許可證申請
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。